These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6369853)

  • 21. Endogenous plasma insulin in a juvenile diabetic after ten years of insulin therapy.
    Johansen K
    Arch Intern Med; 1971 Jan; 127(1):139-40. PubMed ID: 5538984
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of type 1 diabetes with semisynthetic human insulin. 1 year's experience].
    Lunetta M; Rapisarda S; Leonardi R; Leotta S; Mughini L
    Minerva Endocrinol; 1984; 9(2):125-35. PubMed ID: 6390126
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity of monocomponent human and porcine insulin in non-insulin dependent diabetes mellitus.
    Lam HC; Tang KT; Wang JT; Liu YF; Wang LM; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):217-22. PubMed ID: 3052740
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of porcine and semisynthetic human insulins using euglycemic clamp-derived glucose-insulin dose-response curves in insulin-dependent diabetes.
    Staten M; Worcester B; Szekeres A; Waldeck N; Ascher M; Walsh KM; Rizza R; Gerich J; Charles MA
    Metabolism; 1984 Feb; 33(2):132-5. PubMed ID: 6363874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled study of prolonged study with semi-synthetic human insulin.
    Drury R; Keenan P; McEvoy M; Cregan D; Drury MI; Reeves WG
    Ir J Med Sci; 1983 Dec; 152(12):430-4. PubMed ID: 6365832
    [No Abstract]   [Full Text] [Related]  

  • 26. Mixtures of soluble insulin with zinc-suspension or protamine insulin have different effect on blood glucose and free insulin levels in insulin dependent diabetes.
    Lunetta M; Di Mauro M; Mughini L
    Diabete Metab; 1988; 14(3):315-6. PubMed ID: 3044867
    [No Abstract]   [Full Text] [Related]  

  • 27. Biosynthetic human insulin improves postprandial glucose excursions in type I diabetics.
    Gulan M; Gottesman IS; Zinman B
    Ann Intern Med; 1987 Oct; 107(4):506-9. PubMed ID: 3307584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of semisynthetic human insulin in juvenile insulin-dependent diabetes mellitus].
    Sacchetti C; Foco A; David O; Balboni R; Gargano P; Cerutti F; Baratono S
    Minerva Pediatr; 1989 May; 41(5):221-2. PubMed ID: 2677642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of morning hyperglycaemia: determinants of fasting blood glucose concentrations in insulin-treated diabetics.
    Francis AJ; Home PD; Walford S; Alberti KG; Mann N; Reeves WG
    Diabet Med; 1985 Mar; 2(2):89-94. PubMed ID: 2952408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human (semisynthetic) insulin and porcine insulin in the treatment of non-insulin-dependent diabetes. A double-blind, comparative clinical trial.
    Moffitt PS; Colagiuri S; Miller JJ; Hall CA
    Med J Aust; 1984 Feb; 140(4):200-2. PubMed ID: 6363896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin.
    Storms GE; Lutterman JA; van 't Laar A
    Neth J Med; 1986; 29(10):296-302. PubMed ID: 3540688
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study.
    Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R
    Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin.
    Davidson MB; Kumar D; Smith W
    Diabetes Care; 1991 Nov; 14(11):1109-10. PubMed ID: 1797500
    [No Abstract]   [Full Text] [Related]  

  • 34. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of human insulin preparations in the treatment of patients with insulin-dependent diabetes mellitus].
    Perelygina AA; Smirnova OM; Lobanova AM; Gorelysheva VA
    Probl Endokrinol (Mosk); 1988; 34(1):3-5. PubMed ID: 3283725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transferring patients with insulin-dependent diabetes mellitus from animal-source insulins to recombinant DNA human insulin: clinical experience.
    Davidson JK
    Clin Ther; 1989; 11(3):319-30. PubMed ID: 2663162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern aspects of conventional insulin therapy.
    Tattersall RB; McCulloch DK
    Ann Clin Res; 1984; 16(2):107-17. PubMed ID: 6380384
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals.
    Sailer D; Ludwig T; Kolb S
    Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Semisynthetic human insulin in the treatment of diabetes type I. Preliminary experience].
    Vitacolonna E; Consoli A; Capani F
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1849-52. PubMed ID: 6394033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double blind clinical and laboratory study of hypoglycaemia with human and porcine insulin in diabetic patients reporting hypoglycaemia unawareness after transferring to human insulin.
    Maran A; Lomas J; Archibald H; Macdonald IA; Gale EA; Amiel SA
    BMJ; 1993 Jan; 306(6871):167-71. PubMed ID: 8443479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.